111 Capital’s Colgate-Palmolive CL Stock Holding History

111 Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$757K	Buy	8,877 +3,480	+64%	+$315K	0.11%	213
2026 Q2	$495K	Sell	5,397 -3,849	-42%	-$337K	0.09%	239
2026 Q1	$788K	Buy	9,246 +5,824	+170%	+$519K	0.19%	104
2025 Q4	$270K	Sell	3,422 -2,335	-41%	-$183K	0.06%	250
2025 Q3	$460K	Buy	+5,757	New	+$491K	0.09%	232
2025 Q2	–	Sell	-9,373	Closed	-$878K	–	544
2025 Q1	$878K	Buy	9,373 +5,231	+126%	+$468K	0.17%	138
2024 Q4	$377K	Buy	+4,142	New	+$395K	0.08%	261

Other funds holding CL

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

111 Capital's CL Position: Q3 2026 in Review

111 Capital increased its Colgate-Palmolive (CL) stake by 64% in Q3 2026, buying an estimated $315K and bringing the position to 8,877 shares worth $757K. The position accounts for 0.11% of the portfolio, ranked #213.

111 Capital first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $878K in Q1 2025. 1,432 funds tracked by Wall St. Rank hold CL as of Q3 2026.

111 Capital held 8,877 shares of Colgate-Palmolive worth $757K as of Q3 2026.
111 Capital bought 3,480 Colgate-Palmolive shares in Q3 2026, an estimated $315K.
Colgate-Palmolive made up 0.11% of 111 Capital's portfolio in Q3 2026, its #213 holding.
111 Capital first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
111 Capital's Colgate-Palmolive position peaked at $878K in Q1 2025.
1,432 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.